Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Remember, serious side effects are very rare
They provide amino acid building blocks used in connective tissue
It is not available as a licensed medicine through the NHS or any regulated UK pharmacy
Retatrutide's mechanism of action centres on its simultaneous activation of GLP-1, GIP, and glucagon receptors
[1] The synergistic effect of the blend may improve the overall flexibility and adjustability of the tissues following damage
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently without UK marketing authorisation from the MHRA or EMA
US$ 28.99
US$ 22.20
US$ 23.74
US$ 20.75
